Italia markets close in 8 hours 13 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
405,79-13,27 (-3,17%)
Alla chiusura: 04:03PM EST
405,79 0,00 (0,00%)
Dopo ore: 04:46PM EST

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

Settore/iHealthcare
SettoreMedical Devices
Impiegati a tempo pieno8.200

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Norman D. SchwartzChairman, CEO & Pres3,15M26,13M1950
Mr. Ilan DaskalExec. VP & CFO1,18M782,98k1966
Dr. Andrew J. Last Ph.D.Exec. VP & COO1,54M1,03M1960
Mr. Michael CrowleyExec. VP of Global Commercial Operations974,94k1,85M1962
Ms. Dara Grantham WrightExec. VP & Pres of Clinical Diagnostics Group1,06MN/D1976
Mr. Ajit RamalingamSr. VP & Chief Accounting OfficerN/DN/D1973
Mr. Yong ChungVP of Investor RelationsN/DN/DN/D
Mr. Timothy S. ErnstExec. VP, Gen. Counsel & Sec.N/DN/D1960
Colleen CoreySr. VP of Global HRN/DN/DN/D
Lee BoydSr. VP of Global Commercial Operations - Asia PacificN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Governance aziendale

L'ISS Governance QualityScore di Bio-Rad Laboratories, Inc. al 1 dicembre 2022 è 10. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 10; diritti degli azionisti: 10; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.